Yayın:
Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy

Placeholder

Tarih

Akademik Birimler

Kurum Yazarları

Özkan, Hasan Atilla
Hakyemez, Bahattin
Özkalemkaş, Fahir
Ali, Rıdvan
Özkocaman, Vildan
Özçelik, Tülay
Taşkapılıoğlu, Özlem
Altundal, Yıldız
Tunalı, Ayfer

Yazarlar

Danışman

Dil

Türü

Yayıncı:

Springer

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Introduction Reversible posterior leukoencephalopathy syndrome (RPLS) is a recently described clinical and radiological entity comprising headache, seizures, altered level of consciousness and visual disturbances in association with transient posterior cerebral white-matter abnormalities. Method We report a young woman with Burkitt's lymphoma who developed RPLS after combined chemotherapy administered during the tumor lysis syndrome. Results The symptoms in this patient fitted well with those of RPLS; they included abrupt alterations in mental status, seizures, headache, visual changes and characteristic neuroradiological findings. She was given further combination chemotherapy without any neurological complications, at which time she had already recovered from both RPLS and tumor lysis syndrome. Conclusion Although many etiological factors have been reported in the development of RPLS, the underlying mechanism is not yet well understood. With prompt and appropriate management, RPLS is usually reversible, and chemotherapy can be continued after complete recovery from RPLS. We suggest that tumor lysis syndrome should be considered as a contributory factor to the development of RPLS in patients for whom treatment with combined chemotherapy for hematological malignancies is planned.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Neurosciences & neurology, Radiology, nuclear medicine & medical imaging, Tumor lysis syndrome, Reversible posterior leukoencephalopathy syndrome, MRI, Chemotherapy, Leukemia, Lymphoma, Vasospasm, Patient, Combination chemotherapy, Encephalopathy syndrome

Alıntı

Özkan, A. vd. (2006). ''Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy''. Neuroradiology, 48(12), 887-892.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads